Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome

Journal of Heart and Lung Transplantation

Volumn 18, Issue 10, 1999, Pages 1024-1026

  Myers, Janet N ^a   Shabshab, Samir F ^a,b   Burton, Nelson A ^a,b   Nathan, Steven D ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; PRIORITY JOURNAL; SERODIAGNOSIS; THROMBOCYTOPENIA;

CYCLOSPORINE; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TACROLIMUS;

EID: 0032750645     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00056-X     Document Type: Article

References (12)

1. Daufman D.B., Kaplan B., Kanwar Y.S., Abecassis M., Stuart F.P. The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. Transplantation. 59:1995;1737-1739.
2. Abdalla A.H., Al-Sulaiman M.H., Al-Khader A.A. FK 506 as an alternative in cyclosporine-induced hemolytic uremic syndrome in a kidney transplant recipient. Transplant Int. 7:1994;382-384.
3. Schmidt R.J., Venkat K.K., Dumier F. Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. Transplant Proc. 23:1991;3156-3157.
4. Walder B., Ricou B., Suter P.M. Tacrolimus (FK 506) induced hemolytic uremic syndrome after heart transplantation. J Heart Lung Transplant. 17:1998;1004-1006.
5. Randhawa P.S., Shapiro R., Jordan M.L., Starzl T.E., Demetris A.J. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK 506. Am J Surg Pathol. 17:1993;60-68.
6. Randhawa P.S., Tsamandas A.C., Magnone M., et al. Microvascular changes in renal allografts associated with FK 506 (tacrolimus) therapy. Am J Surg Pathol. 20:1996;306-312.
7. Mihatsch M.J., Kyo M., Morozumi K., Yamaguchi Y., Nickeleit V., Ryffel B. The side effects of cyclosporine-A and tacrolimus. Clinical Nephrology. 49:1998;356-363.
8. Singh N., Gayowski T., Marino I.R. Hemolytic uremic syndrome in solid-organ transplant recipients. Transplant Int. 9:1998;68-75.
9. Kahan B.D. Cyclosporine. NEJM. 321:1989;1725-1738.
10. Buturovic J., Kandus A., Malovrh M., et al. Cyclosporine-associated hemolytic uremic syndrome in four renal transplant recipients Resolution without specific therapy . Transplant Proc. 22:1990;1726.
11. Venkat K.K., Tkach D., Kupin W., et al. Reversal of cyclosporine-associated hemolytic uremic syndrome by plasma exchange with fresh frozen plasma replacement in renal transplant recipients. Transplant Proc. 23:1991;1256-1257.
12. Trimarchi H.M., Truong L.D., Brennan S., et al. FK506-associated thrombotic microangiopathy. Transplantation. 67:1999;539-544.